Evaluation of Recombinant Botulinum Neurotoxin Type A1 Efficacy in Peripheral Inflammatory Pain in Mice.

Oehler, Beatrice; Périer, Cindy; Martin, Vincent; Fisher, Amy; Lezmi, Stéphane; Kalinichev, Mikhail; McMahon, Stephen B

Oehler, Beatrice; Périer, Cindy; Martin, Vincent; Fisher, Amy; Lezmi, Stéphane; Kalinichev, Mikhail; McMahon, Stephen B.

Afiliación

Oehler B; Wolfson Center of Age-Related Diseases, IoPPN, Health and Life Science, King's College London, London, United Kingdom.
Périer C; Department of Anaesthesiology, Heidelberg University Hospital, Heidelberg, Germany.
Martin V; Ipsen Innovation, Les Ulis, France.
Fisher A; Ipsen Innovation, Les Ulis, France.
Lezmi S; Transpharmation Ltd., London, United Kingdom.
Kalinichev M; Ipsen Innovation, Les Ulis, France.
McMahon SB; Ipsen Innovation, Les Ulis, France.

Front Mol Neurosci ; 15: 909835, 2022.

Article en En | MEDLINE | ID: mdl-35694440

Palabras clave

GCaMP; analgesia; cleaved SNAP-25; hyperalgesia; in vivo calcium imaging; inflammation; nociception; sensitization

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Mol Neurosci Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google